- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
- You can view the full JPMorgan Chase Ratings Report.
The advisers stand to benefit if the sector sees more deal activity under Trump.
Doug Kass shares his thoughts on biotech, and discusses the shape of things to come.
The idea of buying American and hiring American is good news for defense, ag and energy stocks, says Jim Cramer.